Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29305552

Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2018 Apr 12
First author
Coutre S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2018 Apr 12;131(15):1632-1633. doi: 10.1182/blood-2018-02-826396.
    note
    Source null
    related pmid
    29650729
    relationship
    Comment in

Authors and identifiers

  1. name
    Coutre S
    type
    Author
  2. name
    Choi M
    type
    Author
  3. name
    Furman RR
    type
    Author
  4. name
    Eradat H
    type
    Author
  5. name
    Heffner L
    type
    Author
  6. name
    Jones JA
    type
    Author
  7. name
    Chyla B
    type
    Author
  8. name
    Zhou L
    type
    Author
  9. name
    Agarwal S
    type
    Author
  10. name
    Waskiewicz T
    type
    Author
  11. name
    Verdugo M
    type
    Author
  12. name
    Humerickhouse RA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Coutre S
    type
    Author
  2. name
    Choi M
    type
    Author
  3. name
    Furman RR
    type
    Author
  4. name
    Eradat H
    type
    Author
  5. name
    Heffner L
    type
    Author
  6. name
    Jones JA
    type
    Author
  7. name
    Chyla B
    type
    Author
  8. name
    Zhou L
    type
    Author
  9. name
    Agarwal S
    type
    Author
  10. name
    Waskiewicz T
    type
    Author
  11. name
    Verdugo M
    type
    Author
  12. name
    Humerickhouse RA
    type
    Author
bibliography ids
  1. nci-bib-f237d12eb2757406088354d4
book metadata
content sha256
97717b68e55e20e58d060ba7e0dc16bbc08571f03436d9c0075d2ce4ea8ff071
document type
citation
dois
  1. 10.1182/blood-2017-06-788133
electronic publication date
display
2018 Jan 5
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29305552
immutable id
pubmed:29305552@97717b68e55e20e58d060ba7e0dc16bbc08571f03436d9c0075d2ce4ea8ff071
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
15
name
Blood
nlm unique id
7603509
pages
1704-1711
volume
131
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2018 Apr 12;131(15):1632-1633. doi: 10.1182/blood-2018-02-826396.
    note
    Source null
    related pmid
    29650729
    relationship
    Comment in
outcomes validated
false
pmid
29305552
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
c5411f6b51a38538ac33d60254dc8f96857ef744c3512316dd29ebbc93ea93cc
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Apr 12
precision
day
year
2018
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29305552/
title
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy.

Preserved source evidence · Not medical advice